+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Diabetes Injection Pens Market Research Report by Product (Insulin Pens and Pen Needles), Usage, Distribution Channel, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 226 Pages
  • July 2022
  • Region: Global
  • 360iResearch™
  • ID: 4989869
UP TO OFF until Dec 31st 2022
The Global Diabetes Injection Pens Market size was estimated at USD 14.78 billion in 2021, USD 15.61 billion in 2022, and is projected to grow at a CAGR 5.77% to reach USD 20.70 billion by 2027.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Diabetes Injection Pens to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product, the market was studied across Insulin Pens and Pen Needles.
  • Based on Usage, the market was studied across Disposable and Reusable.
  • Based on Distribution Channel, the market was studied across Diabetes Clinics, Hospital Pharmacy, Online Sales, and Retail Pharmacy.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Diabetes Injection Pens market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Diabetes Injection Pens Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Diabetes Injection Pens Market, including AstraZeneca plc, Becton, Dickinson, and Company, Biocon Ltd., Eli Lilly and Company, Insulet Corporation, Jiangsu Delfu Co., Medtronic Plc, Novo Nordisk A/S, Owen Mumford Ltd, Sanofi S.A, and Ypsomed Holding AG.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Diabetes Injection Pens Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Diabetes Injection Pens Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Diabetes Injection Pens Market?
4. What is the competitive strategic window for opportunities in the Global Diabetes Injection Pens Market?
5. What are the technology trends and regulatory frameworks in the Global Diabetes Injection Pens Market?
6. What is the market share of the leading vendors in the Global Diabetes Injection Pens Market?
7. What modes and strategic moves are considered suitable for entering the Global Diabetes Injection Pens Market?
Frequently Asked Questions about the Global Diabetes Injection Pens Market

What is the estimated value of the Global Diabetes Injection Pens Market?

The Global Diabetes Injection Pens Market was estimated to be valued at $14.78 Billion in 2021.

What is the growth rate of the Global Diabetes Injection Pens Market?

The growth rate of the Global Diabetes Injection Pens Market is 5.7%, with an estimated value of $20.7 Billion by 2027.

What is the forecasted size of the Global Diabetes Injection Pens Market?

The Global Diabetes Injection Pens Market is estimated to be worth $20.7 Billion by 2027.

Who are the key companies in the Global Diabetes Injection Pens Market?

Key companies in the Global Diabetes Injection Pens Market include AstraZeneca plc, Becton, Dickinson, and Company, Biocon Ltd., Eli Lilly and Company, Insulet Corporation, Jiangsu Delfu Co., Medtronic Plc, Novo Nordisk A/S and Sanofi S.A.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of diabetic patients worldwide
5.1.1.2. Demand for intelligent insulin pen
5.1.1.3. Growth in adoption of reusable diabetes injection pen
5.1.2. Restraints
5.1.2.1. Limitation on using certain types of insulin through a pen
5.1.3. Opportunities
5.1.3.1. Easy availability and convenience through e-commerce channel
5.1.3.2. Unmet medical needs in developing nations
5.1.4. Challenges
5.1.4.1. Risk of infection due to improper use
5.2. Cumulative Impact of COVID-19
6. Diabetes Injection Pens Market, by Product
6.1. Introduction
6.2. Insulin Pens
6.3. Pen Needles
7. Diabetes Injection Pens Market, by Usage
7.1. Introduction
7.2. Disposable
7.3. Reusable
8. Diabetes Injection Pens Market, by Distribution Channel
8.1. Introduction
8.2. Diabetes Clinics
8.3. Hospital Pharmacy
8.4. Online Sales
8.5. Retail Pharmacy
9. Americas Diabetes Injection Pens Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Diabetes Injection Pens Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
11. Europe, Middle East & Africa Diabetes Injection Pens Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. AstraZeneca plc
13.2. Becton, Dickinson, and Company
13.3. Biocon Ltd.
13.4. Eli Lilly and Company
13.5. Insulet Corporation
13.6. Jiangsu Delfu Co.
13.7. Medtronic Plc
13.8. Novo Nordisk A/S
13.9. Owen Mumford Ltd
13.10. Sanofi S.A
13.11. Ypsomed Holding AG
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL DIABETES INJECTION PENS MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL DIABETES INJECTION PENS MARKET SIZE, 2021 VS 2027 (USD BILLION)
FIGURE 3. GLOBAL DIABETES INJECTION PENS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 4. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY REGION, 2027
FIGURE 7. GLOBAL DIABETES INJECTION PENS MARKET DYNAMICS
FIGURE 8. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2021 VS 2027 (%)
FIGURE 9. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2021 VS 2027 (USD BILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2027
FIGURE 11. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY INSULIN PENS, 2019-2027 (USD BILLION)
FIGURE 12. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY INSULIN PENS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 13. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY PEN NEEDLES, 2019-2027 (USD BILLION)
FIGURE 14. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY PEN NEEDLES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 15. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2021 VS 2027 (%)
FIGURE 16. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2021 VS 2027 (USD BILLION)
FIGURE 17. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2027
FIGURE 18. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY DISPOSABLE, 2019-2027 (USD BILLION)
FIGURE 19. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY DISPOSABLE, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 20. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY REUSABLE, 2019-2027 (USD BILLION)
FIGURE 21. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY REUSABLE, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 22. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2021 VS 2027 (%)
FIGURE 23. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2021 VS 2027 (USD BILLION)
FIGURE 24. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2027
FIGURE 25. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY DIABETES CLINICS, 2019-2027 (USD BILLION)
FIGURE 26. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY DIABETES CLINICS, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 27. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY HOSPITAL PHARMACY, 2019-2027 (USD BILLION)
FIGURE 28. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 29. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY ONLINE SALES, 2019-2027 (USD BILLION)
FIGURE 30. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY ONLINE SALES, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 31. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY RETAIL PHARMACY, 2019-2027 (USD BILLION)
FIGURE 32. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2021 VS 2027 (USD BILLION)
FIGURE 33. AMERICAS DIABETES INJECTION PENS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 34. AMERICAS DIABETES INJECTION PENS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 35. AMERICAS DIABETES INJECTION PENS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 36. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS DIABETES INJECTION PENS MARKET SIZE, BY COUNTRY, 2027
FIGURE 37. ARGENTINA DIABETES INJECTION PENS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 38. BRAZIL DIABETES INJECTION PENS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 39. CANADA DIABETES INJECTION PENS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 40. MEXICO DIABETES INJECTION PENS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 41. UNITED STATES DIABETES INJECTION PENS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 42. UNITED STATES DIABETES INJECTION PENS MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 43. UNITED STATES DIABETES INJECTION PENS MARKET SIZE, BY STATE, 2021 VS 2027 (USD BILLION)
FIGURE 44. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES DIABETES INJECTION PENS MARKET SIZE, BY STATE, 2027
FIGURE 45. ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 46. ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 47. ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 48. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, BY COUNTRY, 2027
FIGURE 49. AUSTRALIA DIABETES INJECTION PENS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 50. CHINA DIABETES INJECTION PENS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 51. INDIA DIABETES INJECTION PENS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 52. INDONESIA DIABETES INJECTION PENS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 53. JAPAN DIABETES INJECTION PENS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 54. MALAYSIA DIABETES INJECTION PENS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 55. PHILIPPINES DIABETES INJECTION PENS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 56. SINGAPORE DIABETES INJECTION PENS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 57. SOUTH KOREA DIABETES INJECTION PENS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 58. TAIWAN DIABETES INJECTION PENS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 59. THAILAND DIABETES INJECTION PENS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 60. EUROPE, MIDDLE EAST & AFRICA DIABETES INJECTION PENS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 61. EUROPE, MIDDLE EAST & AFRICA DIABETES INJECTION PENS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 62. EUROPE, MIDDLE EAST & AFRICA DIABETES INJECTION PENS MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD BILLION)
FIGURE 63. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA DIABETES INJECTION PENS MARKET SIZE, BY COUNTRY, 2027
FIGURE 64. FRANCE DIABETES INJECTION PENS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 65. GERMANY DIABETES INJECTION PENS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 66. ITALY DIABETES INJECTION PENS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 67. NETHERLANDS DIABETES INJECTION PENS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 68. QATAR DIABETES INJECTION PENS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 69. RUSSIA DIABETES INJECTION PENS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 70. SAUDI ARABIA DIABETES INJECTION PENS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 71. SOUTH AFRICA DIABETES INJECTION PENS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 72. SPAIN DIABETES INJECTION PENS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 73. UNITED ARAB EMIRATES DIABETES INJECTION PENS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 74. UNITED KINGDOM DIABETES INJECTION PENS MARKET SIZE, 2019-2027 (USD BILLION)
FIGURE 75. GLOBAL DIABETES INJECTION PENS MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 76. GLOBAL DIABETES INJECTION PENS MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 77. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL DIABETES INJECTION PENS MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL DIABETES INJECTION PENS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL DIABETES INJECTION PENS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 4. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY REGION, 2019-2027 (USD BILLION)
TABLE 5. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 6. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY INSULIN PENS, BY REGION, 2019-2027 (USD BILLION)
TABLE 7. AMERICAS DIABETES INJECTION PENS MARKET SIZE, BY INSULIN PENS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 8. UNITED STATES DIABETES INJECTION PENS MARKET SIZE, BY INSULIN PENS, BY STATE, 2019-2027 (USD BILLION)
TABLE 9. ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, BY INSULIN PENS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 10. EUROPE, MIDDLE EAST & AFRICA DIABETES INJECTION PENS MARKET SIZE, BY INSULIN PENS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 11. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY PEN NEEDLES, BY REGION, 2019-2027 (USD BILLION)
TABLE 12. AMERICAS DIABETES INJECTION PENS MARKET SIZE, BY PEN NEEDLES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 13. UNITED STATES DIABETES INJECTION PENS MARKET SIZE, BY PEN NEEDLES, BY STATE, 2019-2027 (USD BILLION)
TABLE 14. ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, BY PEN NEEDLES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 15. EUROPE, MIDDLE EAST & AFRICA DIABETES INJECTION PENS MARKET SIZE, BY PEN NEEDLES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 16. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2019-2027 (USD BILLION)
TABLE 17. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY DISPOSABLE, BY REGION, 2019-2027 (USD BILLION)
TABLE 18. AMERICAS DIABETES INJECTION PENS MARKET SIZE, BY DISPOSABLE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 19. UNITED STATES DIABETES INJECTION PENS MARKET SIZE, BY DISPOSABLE, BY STATE, 2019-2027 (USD BILLION)
TABLE 20. ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, BY DISPOSABLE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 21. EUROPE, MIDDLE EAST & AFRICA DIABETES INJECTION PENS MARKET SIZE, BY DISPOSABLE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 22. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY REUSABLE, BY REGION, 2019-2027 (USD BILLION)
TABLE 23. AMERICAS DIABETES INJECTION PENS MARKET SIZE, BY REUSABLE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 24. UNITED STATES DIABETES INJECTION PENS MARKET SIZE, BY REUSABLE, BY STATE, 2019-2027 (USD BILLION)
TABLE 25. ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, BY REUSABLE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 26. EUROPE, MIDDLE EAST & AFRICA DIABETES INJECTION PENS MARKET SIZE, BY REUSABLE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 27. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 28. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY DIABETES CLINICS, BY REGION, 2019-2027 (USD BILLION)
TABLE 29. AMERICAS DIABETES INJECTION PENS MARKET SIZE, BY DIABETES CLINICS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 30. UNITED STATES DIABETES INJECTION PENS MARKET SIZE, BY DIABETES CLINICS, BY STATE, 2019-2027 (USD BILLION)
TABLE 31. ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, BY DIABETES CLINICS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 32. EUROPE, MIDDLE EAST & AFRICA DIABETES INJECTION PENS MARKET SIZE, BY DIABETES CLINICS, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 33. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2019-2027 (USD BILLION)
TABLE 34. AMERICAS DIABETES INJECTION PENS MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 35. UNITED STATES DIABETES INJECTION PENS MARKET SIZE, BY HOSPITAL PHARMACY, BY STATE, 2019-2027 (USD BILLION)
TABLE 36. ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 37. EUROPE, MIDDLE EAST & AFRICA DIABETES INJECTION PENS MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 38. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY ONLINE SALES, BY REGION, 2019-2027 (USD BILLION)
TABLE 39. AMERICAS DIABETES INJECTION PENS MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 40. UNITED STATES DIABETES INJECTION PENS MARKET SIZE, BY ONLINE SALES, BY STATE, 2019-2027 (USD BILLION)
TABLE 41. ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 42. EUROPE, MIDDLE EAST & AFRICA DIABETES INJECTION PENS MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 43. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2019-2027 (USD BILLION)
TABLE 44. AMERICAS DIABETES INJECTION PENS MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 45. UNITED STATES DIABETES INJECTION PENS MARKET SIZE, BY RETAIL PHARMACY, BY STATE, 2019-2027 (USD BILLION)
TABLE 46. ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 47. EUROPE, MIDDLE EAST & AFRICA DIABETES INJECTION PENS MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 48. AMERICAS DIABETES INJECTION PENS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 49. AMERICAS DIABETES INJECTION PENS MARKET SIZE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 50. AMERICAS DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 51. AMERICAS DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2019-2027 (USD BILLION)
TABLE 52. AMERICAS DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 53. ARGENTINA DIABETES INJECTION PENS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 54. ARGENTINA DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 55. ARGENTINA DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2019-2027 (USD BILLION)
TABLE 56. ARGENTINA DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 57. BRAZIL DIABETES INJECTION PENS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 58. BRAZIL DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 59. BRAZIL DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2019-2027 (USD BILLION)
TABLE 60. BRAZIL DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 61. CANADA DIABETES INJECTION PENS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 62. CANADA DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 63. CANADA DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2019-2027 (USD BILLION)
TABLE 64. CANADA DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 65. MEXICO DIABETES INJECTION PENS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 66. MEXICO DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 67. MEXICO DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2019-2027 (USD BILLION)
TABLE 68. MEXICO DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 69. UNITED STATES DIABETES INJECTION PENS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 70. UNITED STATES DIABETES INJECTION PENS MARKET SIZE, BY STATE, 2019-2027 (USD BILLION)
TABLE 71. UNITED STATES DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 72. UNITED STATES DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2019-2027 (USD BILLION)
TABLE 73. UNITED STATES DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 74. ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 75. ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 76. ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 77. ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2019-2027 (USD BILLION)
TABLE 78. ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 79. AUSTRALIA DIABETES INJECTION PENS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 80. AUSTRALIA DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 81. AUSTRALIA DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2019-2027 (USD BILLION)
TABLE 82. AUSTRALIA DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 83. CHINA DIABETES INJECTION PENS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 84. CHINA DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 85. CHINA DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2019-2027 (USD BILLION)
TABLE 86. CHINA DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 87. INDIA DIABETES INJECTION PENS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 88. INDIA DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 89. INDIA DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2019-2027 (USD BILLION)
TABLE 90. INDIA DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 91. INDONESIA DIABETES INJECTION PENS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 92. INDONESIA DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 93. INDONESIA DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2019-2027 (USD BILLION)
TABLE 94. INDONESIA DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 95. JAPAN DIABETES INJECTION PENS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 96. JAPAN DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 97. JAPAN DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2019-2027 (USD BILLION)
TABLE 98. JAPAN DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 99. MALAYSIA DIABETES INJECTION PENS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 100. MALAYSIA DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 101. MALAYSIA DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2019-2027 (USD BILLION)
TABLE 102. MALAYSIA DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 103. PHILIPPINES DIABETES INJECTION PENS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 104. PHILIPPINES DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 105. PHILIPPINES DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2019-2027 (USD BILLION)
TABLE 106. PHILIPPINES DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 107. SINGAPORE DIABETES INJECTION PENS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 108. SINGAPORE DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 109. SINGAPORE DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2019-2027 (USD BILLION)
TABLE 110. SINGAPORE DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 111. SOUTH KOREA DIABETES INJECTION PENS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 112. SOUTH KOREA DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 113. SOUTH KOREA DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2019-2027 (USD BILLION)
TABLE 114. SOUTH KOREA DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 115. TAIWAN DIABETES INJECTION PENS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 116. TAIWAN DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 117. TAIWAN DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2019-2027 (USD BILLION)
TABLE 118. TAIWAN DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 119. THAILAND DIABETES INJECTION PENS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 120. THAILAND DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 121. THAILAND DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2019-2027 (USD BILLION)
TABLE 122. THAILAND DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA DIABETES INJECTION PENS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA DIABETES INJECTION PENS MARKET SIZE, BY COUNTRY, 2019-2027 (USD BILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2019-2027 (USD BILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 128. FRANCE DIABETES INJECTION PENS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 129. FRANCE DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 130. FRANCE DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2019-2027 (USD BILLION)
TABLE 131. FRANCE DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 132. GERMANY DIABETES INJECTION PENS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 133. GERMANY DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 134. GERMANY DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2019-2027 (USD BILLION)
TABLE 135. GERMANY DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 136. ITALY DIABETES INJECTION PENS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 137. ITALY DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 138. ITALY DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2019-2027 (USD BILLION)
TABLE 139. ITALY DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 140. NETHERLANDS DIABETES INJECTION PENS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 141. NETHERLANDS DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 142. NETHERLANDS DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2019-2027 (USD BILLION)
TABLE 143. NETHERLANDS DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 144. QATAR DIABETES INJECTION PENS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 145. QATAR DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 146. QATAR DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2019-2027 (USD BILLION)
TABLE 147. QATAR DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 148. RUSSIA DIABETES INJECTION PENS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 149. RUSSIA DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 150. RUSSIA DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2019-2027 (USD BILLION)
TABLE 151. RUSSIA DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 152. SAUDI ARABIA DIABETES INJECTION PENS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 153. SAUDI ARABIA DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 154. SAUDI ARABIA DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2019-2027 (USD BILLION)
TABLE 155. SAUDI ARABIA DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 156. SOUTH AFRICA DIABETES INJECTION PENS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 157. SOUTH AFRICA DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 158. SOUTH AFRICA DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2019-2027 (USD BILLION)
TABLE 159. SOUTH AFRICA DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 160. SPAIN DIABETES INJECTION PENS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 161. SPAIN DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 162. SPAIN DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2019-2027 (USD BILLION)
TABLE 163. SPAIN DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 164. UNITED ARAB EMIRATES DIABETES INJECTION PENS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 165. UNITED ARAB EMIRATES DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 166. UNITED ARAB EMIRATES DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2019-2027 (USD BILLION)
TABLE 167. UNITED ARAB EMIRATES DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 168. UNITED KINGDOM DIABETES INJECTION PENS MARKET SIZE, 2019-2027 (USD BILLION)
TABLE 169. UNITED KINGDOM DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2019-2027 (USD BILLION)
TABLE 170. UNITED KINGDOM DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2019-2027 (USD BILLION)
TABLE 171. UNITED KINGDOM DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD BILLION)
TABLE 172. GLOBAL DIABETES INJECTION PENS MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 173. GLOBAL DIABETES INJECTION PENS MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 174. GLOBAL DIABETES INJECTION PENS MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 175. GLOBAL DIABETES INJECTION PENS MARKET RANKING
TABLE 176. GLOBAL DIABETES INJECTION PENS MARKET SHARE, BY KEY PLAYER, 2021
TABLE 177. GLOBAL DIABETES INJECTION PENS MARKET MERGER & ACQUISITION
TABLE 178. GLOBAL DIABETES INJECTION PENS MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 179. GLOBAL DIABETES INJECTION PENS MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 180. GLOBAL DIABETES INJECTION PENS MARKET INVESTMENT & FUNDING
TABLE 181. GLOBAL DIABETES INJECTION PENS MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 182. GLOBAL DIABETES INJECTION PENS MARKET: LICENSE & PRICING

Companies Mentioned

  • AstraZeneca plc
  • Becton, Dickinson, and Company
  • Biocon Ltd.
  • Eli Lilly and Company
  • Insulet Corporation
  • Jiangsu Delfu Co.
  • Medtronic Plc
  • Novo Nordisk A/S
  • Owen Mumford Ltd
  • Sanofi S.A
  • Ypsomed Holding AG

Methodology

Loading
LOADING...